Stay updated on Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial page.

Latest updates to the Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new revision entry 'Revision: v3.6.5' was added to the study record history. The previous entry 'Revision: v3.6.4' was removed.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe record history now includes a new revision entry 'v3.6.4' and removes the previous 'v3.6.3' entry. This indicates an update to the page's versioning metadata rather than changes to trial data or study details.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision entry v3.6.3 is added to the study record history, and the previous revision v3.6.2 is removed, reflecting an update to the revision history.SummaryDifference0.1%

- Check51 days agoChange DetectedThe history now includes the latest site revision label, v3.6.2, replacing the prior v3.6.0. This reflects an internal deployment update and does not affect trial data or content.SummaryDifference0.1%

- Check66 days agoChange DetectedA new revision entry v3.6.0 was added to the study record, along with a note that the study is no longer looking for participants. The previous revision entry v3.5.5 has been removed from the history.SummaryDifference0.6%

- Check73 days agoChange DetectedThe history shows a new site revision (v3.5.5) replacing the previous revision, indicating a software release or UI update rather than changes to the study information.SummaryDifference0.1%

Stay in the know with updates to Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial page.